Efgartigimod as rescue treatment in acute phase of neuromyelitis optica spectrum disorder: A Case Report
Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is a central nervous system demyelinating disease. Current therapy methods, however, have limited effect on acute attacks except for intravenous methylprednisolone (IVMP). Efgartigimod is a first-in-class novel human immunoglobulin G1 (IgG...
Gardado en:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2024-05-01
|
| Series: | Heliyon |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2405844024064521 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|